Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2000 Sep;44(9):2590-2.
doi: 10.1128/AAC.44.9.2590-2592.2000.

Establishing criteria for assessment of efficacy of antimicrobial agents in acute otitis media

W Erhardt, M Murphy, C Knirsch
Comment

Establishing criteria for assessment of efficacy of antimicrobial agents in acute otitis media

W Erhardt et al. Antimicrob Agents Chemother. 2000 Sep.
No abstract available

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Median time to second tympanocentesis. For azithromycin (AZ) the median was 4 days (range, 3 to 6 days). For cefaclor (CFC) the median was 5 days (range, 4 to 6 days). P = 0.1044.
See this image and copyright information in PMC

Comment on

References

    1. Dagan R, Leibovitz E, Fliss D M, Leiberman A, Jacobs M R, Craig W, Yagupsky P. Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children. Antimicrob Agents Chemother. 2000;44:43–50. - PMC - PubMed
    1. Dagan R, Leibovitz E, Fliss D M, Leiberman A, Jacobs M R, Craig W, Yagupsky P. Early eradication of pathogens from middle ear fluid during antibiotic treatment of acute otitis media is associated with improved clinical outcome. Pediatr Infect Dis J. 1998;17:776–782. - PubMed
    1. Food and Drug Administration. Draft guidance for industry. Acute otitis media—developing antimicrobial drugs for treatment. Rockville, Md: FDA Center for Drug Evaluation and Research; 1998.
    1. Gladue R P, Bright G M, Isaacson R E, Newborg M F. In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob Agents Chemother. 1989;33:277–282. - PMC - PubMed
    1. Howie V M, Ploussard J H. “The in-vivo sensitivity test”: bacteriology of middle ear exudate during antimicrobial therapy in otitis media. Pediatrics. 1969;44:940–944. - PubMed

MeSH terms